靶向大鼠Smad3基因的siRNA筛选及其shRNA重组慢病毒的构建

陈鹏; 郑素军; 王世美; 张建军; 邢欣悦; 张莹; 刘梅; 段钟平

靶向大鼠Smad3基因的siRNA筛选及其shRNA重组慢病毒的构建

1. 首都医科大学附属北京佑安医院人工肝中心
2. 泸州医学院

基金项目:

国家自然科学基金资助项目(30800979)；北京自然科学基金资助项目(7102085)；北京市科技新星资助项目(2007B055)；首都医科大学基础-临床科研合作基金(2007JL022010JL02)；

详细信息

中图分类号: R363
计量
- 文章访问数: 214
- HTML全文浏览量: 17
- PDF下载量: 275
- 被引次数: 0
出版历程
- 出版日期: 2011-05-20

Selection of siRNA and construction of recombinant lentivirus expressing shRNA targeting rat Smad3 gene

Research funding:

摘要

摘要: 目的设计并筛选针对大鼠Smad3基因的siRNA,构建靶向Smad3基因的shRNA重组慢病毒。方法针对大鼠Smad3基因设计并合成6对siRNA（siRNA001～006）及1对无关对照siRNA,转染大鼠肝细胞株BRL-3A,应用Western Blot检测各siRNA对SMAD3蛋白表达的抑制作用,挑选抑制效率高的siRNA。依据所得的序列合成并克隆到pLL3.7载体中,与包装质粒pRSV-rev、pMDLg-pRRE和VSV-G共转染293FT细胞获得靶向Smad3的慢病毒。通过流式细胞仪绿色荧光蛋白（GFP）荧光计数来检测病毒滴度。结果 Western Blot检测证实siRNA001、siRNA005、siRNA006对SMAD3蛋白表达的抑制作用明显,抑制率分别可达83.36%、86.99%及64.88%,而对照siRNA无明显作用。酶切和测序结果显示Smad3 shRNA及对照shRNA重组载体质粒pLL3.7-shRNA构建成功,将构建的质粒进行慢病毒包装可产生有感染活性的慢病毒颗粒。结论筛选出针对大鼠Smad3基因有明显抑制作用的3对siRNA,并成功构建表达相应s...
- SMAD3蛋白质 /
- RNA干扰 /
- RNA,小分子干扰 /
- 慢病毒属
Abstract: Objective To design and select the siRNA targeting rat Smad3 gene and construct recombinant lentivirus expressing Smad3 small hairpin RNA (shRNA) .Methods Six pairs of siRNAs of rat smad3 gene named as siRNA 001-006 and an irrelevant siRNA were designed and synthesized.The siRNAs were transfected into the rat liver cell line BRL-3A, and the inhibitory effects on SMAD3 protein expression were determined by Western Blot.According to the efficient siRNAs and irrelevant siRNA sequences, DNA sequences coding corresponding shRNAs were synthesized and inserted into plasmid plentilox3.7-shRNA (pLL3.7-shRNA) .Then, the pLL3.7-shRNA, pRSV-rev, pMDLG/pRRE and VSV-G were transfected into 293FT cells together to package lentivirus.Infective vector titers were determined by GFP gene expression analysis using flow cytometry.Results Western Blot analysis demonstrated that siRNA001, siRNA005 and siRNA006 had high interfering efficiency, with the inhibitory rate being 83.36%, 86.99% and 64.88%, respectively.Meanwhile, the irrelevant siRNA had no apparent effect.Enzyme digestion and DNA sequencing results showed that shRNA recombinant vector pLL3.7-shRNA were constructed successfully.Infective lentivirus have been produced.Conclusion Three siRNAs targeted to rat Smad3 gene have been selected.The recombinant lentivirus which express corresponding shRNA have been constructed successfully, laying foundations for further studying the influence on liver regeneration or liver fibrosis after Smad3 silence.
- SMAD3 protein /
- RNA inter ference /
- RNA /
- small interfering

HTML全文

参考文献(31)

[1]Han C, Bowen WC, Li G, et al.Cytosolic phospholipase A2alpha and peroxisome proliferator-activated receptor gamma signaling pathway counteracts transforming growth factor beta-mediated inhibition of primary and transformed hepatocyte growth[J].Hepatology, 2010, 52 (2) :644-655.

[2]de Gouville AC, Boullay V, Krysa G, et al.Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis[J].Br J Pharmacol, 2005, 145 (2) :166-177.

[3] Michalopoulos GK.Liver regeneration[J].J Cell Physiol, 2007, 213 (2) :286-300.临床肝胆病杂志2011年第27卷第5期

[4]Nguyen LN, Furuya MH, Wolfraim LA, et al.Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation[J].Hepatology, 2007, 45 (1) :31-41.

[5]Thenappan A, Li Y, Kitisin K, et al.Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver[J].Hepatology, 2010, 51 (4) :1373-1382.

[6]Zhong Z, Tsukada S, Rehman H, et al.Inhibition of transforming growth factor-beta/Smad signaling improves regeneration of small-for-size rat liver grafts[J].Liver Transpl, 2010, 16 (2) :181-190.

[7]Mayoral R, Valverde AM, Llorente Izquierdo C, et al.Impairment of transforming growth factor beta signaling in caveolin-1-deficient hepatocytes:role in liver regeneration[J].J Biol Chem, 2010, 285 (6) :3633-3642.

[8]Hughes RD, Evans LW.Activin A and follistatin in acute liver failure[J].Eur J Gastroenterol Hepatol, 2003, 15 (2) :127-131.

[9]Rodgarkia-Dara C, Vejda S, Erlach N, et al.The activin axis in liver biology and disease[J].Mutat Res, 2006, 613 (2-3) :123-137.

[10]Takamura K, Tsuchida K, Miyake H, et al.Activin and activin receptor expression changes in liver regeneration in rat[J].J Surg Res, 2005, 126 (1) :3-11.

[11]Lin SD, Kawakami T, Ushio A, et al.Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure[J].J Gastroenterol Hepatol, 2006, 21 (2) :374-380.

[12]Soliman GM, Mohammed KA, Taha A, et al.The role ofplasma transforming growth factor beta-1 in the development of fibrosis in patient with HCV related steatohepatitis[J].J Egypt Soc Parasitol, 2010, 40 (3) :759-772.

[13]Wu XL, Zeng WZ, Jiang MD, et al.Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis[J].World J Gastroenterol, 2008, 14 (13) :2100-2105.

[14]Parsons CJ, Takashima M, Rippe RA.Molecular mechanisms of hepatic fibrogenesis[J].J Gastroenterol Hepatol, 2007, 22 (Suppl 1) :S79-84.

[15]Inagaki Y, Okazaki I.Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis[J].Gut, 2007, 56 (2) :284-292.

[16]Cirrose hepáticaecélulas estreladas do figado.Liver cirrhosis and hepatic stellate cells[J].Acta Cirúrgica Brasileira, 2006, 21 (Suppl 1) :54-57.

[17]Date M, Matsuzaki K, MatsushitaM, et al.Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat live injury[J].J Hepatol, 2000, 32 (2) :251-260.

[18]Chen YG, Lui HM, Lin SL, et al.Regulation of cell proliferation, apoptosis, and carcinogenesis by activin[J].Exp Biol Med (Maywood) , 2002, 227 (2) :75-87.

[19]Nishitsuji H, Kohara M, Kannagi M, et al.Effective suppression of human immunodeficiency virus type 1 through a combination of short-or long-hairpin RNAs targeting essential sequences for retroviral integration[J].J Virol, 2006, 80 (15) :7658-7666.

[20]Grimm D, Kay MA.RNAi and gene therapy:a mutual attraction[J].Hematology, 2007, (1) :473-481.

[21]Kreidl E, Oztürk D, Metzner T, et al.Activins and follistatins:Emerging roles in liver physiology and cancer[J].World J Hepatol, 2009, 1 (1) :17-27.

[22]Wanninger J, Neumeier M, Hellerbrand C, et al.Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes[J].Biochim Biophys Acta, 2010.[Epub ahead of print]

[23]Romero-Gallo J, Sozmen EG, Chytil A, et al.Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy[J].Oncogene, 2005, 24 (18) :3028-3041.

[24]Takabe K, Wang L, Leal AM, et al.Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats[J].Hepatology, 2003, 38:1107-1115.

[25]Katja B, Stephan H, Eliza W, et al.Anti-TGF-strategies for the treatment of chronic liver disease[J].Alcohol Clin Exp Res, 2005, 29 (11) :121S-131S.

[26]Patella S, Phillips DJ, Tchongue J, et al.Follistatin attenuates early liver fibrosis:effects on hepatic stellate cell activation and hepatocyte apoptosis[J].Am J Physiol Gastrointest Liver Physiol, 2006, 290 (1) :G137-144.

[27]Du SS, Qiang M, Zeng ZC, et al.Radiation-induced liver fibrosis is mitigated by gene therapy inhibiting transforming growth factor-βsignaling in the rat[J].Int J Radiat Oncol Biol Phys, 2010, 78 (5) :1513-1523.

[28]Zhou J, Zhong DW, Wang QW, et al.Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity[J].World J Gastroenterol, 2010, 16 (26) :3330-3334.

[29]Sharp PA.RNA interference-2001[J].Genes Dev, 2001, 15 (5) :485-490.

[30]Miest T, Saenz D, Meehan A, et al.Intensive RNAi with lentiviral vectors in mammalian cells[J].Methods, 2009, 47 (4) :298-303.

[31]Kusov Y, Kanda T, Palmenberg A, et al.Silencing of hepatitis A virus infection by small interfering RNAs[J].J Virol, 2006, 80 (11) :5599-5610.

施引文献

资源附件(0)

访问统计